Continuous Temperature Measurement by Thermal Imaging Camera
TermoCamUCI
1 other identifier
observational
224
0 countries
N/A
Brief Summary
This study explores the significance of body temperature monitoring in hospitalized patients, particularly in critical care environments. With body temperature exhibiting considerable variability, fever, defined at a central temperature of 38.3°C, serves as a pertinent indicator across diverse medical conditions. Temperature measurement methods in Intensive Care Units (ICUs) range from routine peripheral measurements to more invasive central temperature monitoring. Critical patients with fever often receive antibiotic treatment, even without conclusive evidence of infection, as early intervention is linked to improved survival in septic patients. However, the complexity of individual variability, circadian rhythms, medication effects, and methodological limitations underscores the impracticality of defining fever with a singular temperature value. The thermal curve, representing the temporal evolution of temperature, emerges as a nuanced parameter in this context. This study seeks to establish the correlation between axillary temperature measurements, a conventional method, and temperatures recorded by thermal imaging cameras. Widely employed during the Covid-19 pandemic, these cameras offer non-invasive and contactless measurement, mitigating pathogen transmission risks, particularly in patients colonized by multidrug-resistant microorganisms or those with compromised skin integrity. The study also endeavors to evaluate the diagnostic validity of thermal imaging cameras for fever and hypothermia. The integration of thermal imaging cameras into a system capable of automated, real-time peripheral temperature acquisition suggests a potential paradigm shift in ICU temperature monitoring practices. Beyond immediate clinical applications, the amassed data from this system holds promise for training intelligent systems through machine learning algorithms. This strategic integration aims to predict critical events, such as the onset of fever, nosocomial infections, or shock, marking a forward-looking approach to patient management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 13, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedFebruary 13, 2024
February 1, 2024
9 months
February 5, 2024
February 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concordance between thermal imaging camera and axillary contact thermometer
To assess the concordance of temperature obtained continuously by a thermal imaging camera with that obtained by an axillary contact thermometer
10 months
Secondary Outcomes (6)
Sociodemographic and clinical characteristics of the study population.
10 months
Test validity for fever and hypothermia
10 months
Difference until fever detection
10 months
Thermal curve patterns
10 months
Thermal curve patterns in patients with infection upon admission and patients who develop infection during admission
10 months
- +1 more secondary outcomes
Study Arms (1)
Critical care patients
Eligibility Criteria
The study will be conducted on all patients admitted to the ICU rooms at HLA Moncloa University Hospital, equipped with an infrared camera for continuous measurement of skin temperature
You may qualify if:
- Patients admitted to the ICU in a room with a thermal imaging camera
- Patients who provide voluntary consent to participate in the study (Annex 2). If the participant is not in full physical or intellectual capacity to provide their signature in the informed consent, the responsible investigator will seek consent from their direct family member or the legally designated person to make decisions on their behalf regarding health matters. This measure is adopted to ensure the participant's rights are respected and the integrity of the consent process is maintained, even in situations where their decision-making capacity may be compromised.
You may not qualify if:
- Patients from whom information from the thermal imaging camera cannot be obtained due to technical reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad Europea de Madridlead
- Fundación ASISAcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 5, 2024
First Posted
February 13, 2024
Study Start
March 1, 2024
Primary Completion
December 1, 2024
Study Completion
January 1, 2025
Last Updated
February 13, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share